Company profile
Levicept company profile
With more than 1 billion people worldwide living with some type of chronic pain, a large unmet medical need for safe and effective analgesics exists. Traditional non-steroidal anti-inflammatory drugs (NSAIDs) are the most widely used drugs to treat pain and inflammation associated with osteoarthritis, but their use is limited by adverse effects on gastrointestinal and platelet function, as well as increased cardiovascular liability. Levicept is an asset-centric UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. We are progressing LEVI-04 to phase I clinical trials to test its efficacy and..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.levicept.com/
- Contact email
- [email protected]
- Phone number
- (447) 590-8153
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2012-01-01
Headquarters
- Headquarters
- Kent, Sandwich, United Kingdom
- Postal code
- CT13 9ND
- Country code
- GB
- Continent
- Europe